nach oben

PharmacoEconomics

Erschienen in:

01.02.2015 | Practical Application

A Practical Guide to Value of Information Analysis

verfasst von: Edward C. F. Wilson

Erschienen in: PharmacoEconomics | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Value of information analysis is a quantitative method to estimate the return on investment in proposed research projects. It can be used in a number of ways. Funders of research may find it useful to rank projects in terms of the expected return on investment from a variety of competing projects. Alternatively, trialists can use the principles to identify the efficient sample size of a proposed study as an alternative to traditional power calculations, and finally, a value of information analysis can be conducted alongside an economic evaluation as a quantitative adjunct to the ‘future research’ or ‘next steps’ section of a study write up. The purpose of this paper is to present a brief introduction to the methods, a step-by-step guide to calculation and a discussion of issues that arise in their application to healthcare decision making. Worked examples are provided in the accompanying online appendices as Microsoft Excel spreadsheets.

Nur mit Berechtigung zugänglich

Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. In: Senn S, Barnett V, editors. Statistics in practice. Chichester: Wiley; 2004. p. 25.

Pratt J, Raiffa H, Schlaifer R. Introduction to statistical decision theory. Cambridge: Massachusetts Institute of Technology; 1995.

Henriksson M, Lundgren F, Carlsson P. Informing the efficient use of health care and health care research resources—the case of screening for abdominal aortic aneurysm in Sweden. Health Econ. 2006;15(12):1311–22.PubMedCrossRef

Garside R, Pitt M, Somerville M, et al. Surveillance of Barrett’s oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess. 2006;10(8):1–158.PubMedCrossRef

Robinson M, Palmer S, Sculpher M, et al. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling. Health Technol Assess. 2005;9(27):3–4 (9–11, 1–158).CrossRef

Tappenden P, Chilcott JB, Eggington S, et al. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. Health Technol Assess. 2004;8(27):3 (1–78).CrossRef

Iglesias CP, Claxton K. Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcers. Pharmacoeconomics. 2006;24(5):465–78.PubMedCrossRef

Castelnuovo E, Thompson-Coon J, Pitt M, et al. The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess. 2006;10(32):3–4 (9–12, 1–93).CrossRef

Bartell SM, Ponce RA, Takaro TK, et al. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention. Risk Anal. 2000;20(1):87–99.PubMedCrossRef

10.

Wilson EC, Gurusamy K, Samraj K, et al. A cost utility and value of information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 2010;97:210–9.PubMedCrossRef

11.

Gurusamy K, Wilson E, Burroughs AK, et al. Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones: cost-utility and value-of-information analysis. Appl Health Econ Health Policy. 2012;10(1):15–29. doi:10.2165/11594950-000000000-00000.PubMedCrossRef

12.

Wilson EC, Emery JD, Kinmonth AL, et al. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health. 2013;16(2):356–66. doi:10.1016/j.jval.2012.12.008.PubMedCrossRef

13.

Raiffa H, Schlaifer R. Probability and statistics for business decisions. New York: McGraw Hill; 1959.

14.

Raiffa H, Schlaifer R. Applied statistical decision theory. Boston: Harvard Business School; 1961.

15.

Thompson MS. Decision-analytic determination of study size. The case of electronic fetal monitoring. Med Decis Making. 1981;1(2):165–79.PubMedCrossRef

16.

Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341–64 (S0167-6296(98)00039-3 [pii]).PubMedCrossRef

17.

Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ. 2007;16(2):195–209. doi:10.1002/hec.1161.PubMedCrossRef

18.

Willan A, Briggs A. Power and sample size determination: the value of information approach. Statistical analysis of cost-effectiveness data. Chichester: Wiley; 2006. p. 108–16.

19.

Banta HD, Thacker SB. The case for reassessment of health care technology: once is not enough. JAMA. 1990;264:235–40.PubMedCrossRef

20.

Fenwick E, Claxton K, Sculpher M, et al. Improving the efficiency and relevance of health technology assessment: the role of decision analytic modelling. Centre for Health Economics Discussion paper 179. York: Centre for Health Economics, University of York; 2000.

21.

Sculpher M, Drummond M, Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy. 1997;2(1):26–30.PubMed

22.

Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15(7):677–87.PubMedCrossRef

23.

Wilson E, Abrams K. From evidence based economics to economics Based evidence: using systematic review to inform the design of future research. In: Shemilt I, Mugford M, Vale L, et al., editors. Evidence based economics. London: Blackwell Publishing; 2010.

24.

Drummond M, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.

25.

Cachon GR, Terwiesch C. Matching supply with demand: an introduction to operations management. 3rd ed. New York: McGraw-Hill; 2013.

26.

Willan AR, Pinto EM. The value of information and optimal clinical trial design. Stat Med. 2005;24(12):1791–806.PubMedCrossRef

27.

Steuten L, van de Wetering G, Groothuis-Oudshoorn K, et al. A systematic and critical review of the evolving methods and applications of value of information in academia and practice. Pharmacoeconomics. 2013;31(1):25–48. doi:10.1007/s40273-012-0008-3.PubMedCrossRef

28.

Philips Z, Claxton K, Palmer S. The half-life of truth: what are appropriate time horizons for research decisions? Med Decis Making. 2008;28(3):287–99. doi:10.1177/0272989X07312724.PubMedCrossRef

29.

McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Med Decis Making. 2011;31(6):853–65. doi:10.1177/0272989X11399921.PubMedCrossRef

30.

Eckermann S, Willan AR. The option value of delay in health technology assessment. Med Decis Making. 2008;28(3):300–5. doi:10.1177/0272989X07312477.PubMedCrossRef

31.

Bernanke BS. Irreversibility, uncertainty, and cyclical investment. Q J Econ. 1983;98(1):85–106. doi:10.2307/1885568.CrossRef

32.

Eckermann S, Willan AR. Globally optimal trial design for local decision making. Health Econ. 2009;18(2):203–16. doi:10.1002/hec.1353.PubMedCrossRef

33.

Briggs AH, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.

34.

Briggs AH, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Handbooks in health economic evaluation. Oxford: Oxford University Press; 2006. p. 95.

35.

Gelman A, Carlin JB, Stern HS, et al. Bayesian data analysis. London: Chapman and Hall; 1995.

36.

Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24(2):207–27. doi:10.1177/0272989X04263162.PubMedCrossRef

37.

O’Hagan A, Buck CE, Daneshkhah A, et al. Uncertain judgements: eliciting experts’ probabilities. Chichester: Wiley; 2006.CrossRef

38.

Higgins JP, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med. 2008;27(29):6072–92. doi:10.1002/sim.3427.PubMedCentralPubMedCrossRef

39.

Mathworks Documentation Center: Lognormal mean and variance. http://www.mathworks.co.uk/help/stats/lognstat.html. Last Accessed 11 January 2014.

40.

MrExcel.com, Your one stop for Excel tips and solutions. http://www.mrexcel.com/forum/excel-questions/507508-reverse-poisson.html. Last Accessed 11 January 2014.

Titel: A Practical Guide to Value of Information Analysis
verfasst von: Edward C. F. Wilson
Publikationsdatum: 01.02.2015
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 2/2015
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.1007/s40273-014-0219-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

A Practical Guide to Value of Information Analysis

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies

Refitting of the UKPDS 68 Risk Equations to Contemporary Routine Clinical Practice Data in the UK

Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal

A Primer on Marginal Effects—Part II: Health Services Research Applications

Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

Biological Therapies for the Treatment of Severe Psoriasis in Patients with Previous Exposure to Biological Therapy: A Cost-Effectiveness Analysis